CA Patent

CA2860323C — Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation

Assigned to Global Blood Therapeutics Inc · Expires 2022-03-08 · 4y expired

What this patent protects

Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods of their use in treating disorders mediate by hemogl…

USPTO Abstract

Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods of their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation. The compound of Formula (l) represents the new substituted benzaldehydes.

Drugs covered by this patent

Patent Metadata

Patent number
CA2860323C
Jurisdiction
CA
Classification
—
Expires
2022-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Global Blood Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.